ER STIEHM, LEEH KRONENBERG, … - Annals of Internal …, 1982 - annals.org.p.angrylapdog.com Interferons are proteins elaborated by infected cells that protect noninfected cells from viral
infection. These proteins produce a temporary "antiviral state" by altering nucleotide metabolism
and cytoplasmic enzyme induction. Interferons appear early after viral infection locally ... Cited by 119 - Related articles - All 3 versions
SE Krown, FX Real, S Cunningham-Rundles, … - New England Journal …, 1983 - content.nejm.org Original Article from The New England Journal of Medicine -- Preliminary observations on the
effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma.
Cited by 245 - Related articles - All 2 versions
JU GUTTERMAN, S FINE, J QUESADA, SJ … - Annals of Internal …, 1982 - Am Coll Physicians Sixteen patients with advanced cancer were treated with recombinant-DNA-produced pure leukocyte
A interferon (IFLrA) intramuscularly in doses ranging from 3 to 198 X 10 6 units, with interval
periods of 72 to 96 hours between doses. At the two lowest doses of 3 and 9 million units, ... Cited by 280 - Related articles - All 2 versions
- ►nih.gov [PDF] AS Lau, GE Hannigan, MH Freedman, … - Journal of Clinical …, 1986 - pubmedcentral.nih.gov Interferons (IFN) elicit antiviral and antineoplastic activities by binding to specific receptors on
the cellsurface. The binding characteristics of IFN to human lymphocytes were studied using
IFN a2 labeled with '25I to high specific activity. The specific bindingcurves generated ... Cited by 50 - Related articles - All 6 versions
… , RT MITSUYASU, MA CONANT, H PRINCE, … - Annals of internal …, 1984 - Am Coll Physicians In a randomized prospective study we tested the toxicity and efficacy of recombinant alpha-2
interferon in the treatment of Kaposi's sarcoma associated with the acquired immunodeficiency
syndrome. High doses (50 X 10 6 U/m 2 body surface area, intravenously) or low doses ... Cited by 202 - Related articles - All 5 versions
EP Gelmann, OT Preble, R Steis, HC Lane, AH … - The American journal of …, 1985 - Elsevier Thirty consecutive patients with the acquired immune deficiency syndrome were treated with
intramuscular human lymphoblastoid interferon for Kaposi's sarcoma. Patients were divided
Into three groups receiving 7.5 million units/m 2 per day, 15 million units/m 2 per day, or ... Cited by 68 - Related articles - All 3 versions
EF Wheelock, S Schenker, B Combes - Proceedings of the Society for …, 1968 - ncbi.nlm.nih.gov 1: Proc Soc Exp Biol Med. 1968 May;128(1):251-3. Absence of circulating interferon
in patients with infectious and serum hepatitis. Wheelock EF, Schenker S, Combes
B. Mesh Terms: Aspartate Aminotransferases/blood; Hepatitis ... Cited by 32 - Related articles - All 2 versions
DA Hill, JH Walsh, RH Purcell - … of the Society for Experimental Biology …, 1971 - ncbi.nlm.nih.gov 1: Proc Soc Exp Biol Med. 1971 Mar;136(3):853-6. Failure to demonstrate circulating
interferon during incubation period and acute stage of transfusion-associated
hepatitis. Hill DA, Walsh JH, Purcell RH. Mesh Terms: Acute ... Cited by 36 - Related articles - All 2 versions
P Tolentino, F Dianzani, M Zucca, R … - Journal of interferon …, 1992 - liebertonline.com Page 1. JOURNAL OF INTERFERON RESEARCH Special Issue, May 1992 Mary Ann Liebert,
Inc., Publishers Decreased Interferon Response by Lymphocytes from Children with Chronic
Hepatitis P. TOLENTINO, F. DIANZANI, M. ZUCCA, and R. GIACCHINO ABSTRACT ... Cited by 39 - Related articles - All 5 versions
M Krim - Blood, 1980 - bloodjournal.hematologylibrary.org . Hematology; all rights reserved Copyright 2007 by The American Society of DC 20036. by the
American Society of Hematology, 1900 M St, NW, Suite 200, Washington Blood (print ISSN
0006-4971, online ISSN 1528-0020), is published semimonthly ... For personal use only. ... Cited by 41 - Related articles - View as HTML - All 4 versions
